Sebree Terri B
Insider CIK 1297912 · PATH President · ZYNE President
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 125,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 341,241 | — | $0 | 255,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-10-10 | 2023-10-11 | 170,000 | — | $0 | 425,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 425,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-09-13 | 2023-09-14 | 12,401 | $1.33 | $16.5K | 596,241 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-09-12 | 2023-09-14 | 45,000 | — | $0 | 608,642 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | F Tax w/h | 2023-02-08 | 2023-02-09 | 9,973 | $0.60 | $6.0K | 563,642 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-02-07 | 2023-02-09 | 36,044 | — | $0 | 573,615 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | F Tax w/h | 2023-02-01 | 2023-02-02 | 9,321 | $0.60 | $5.6K | 537,571 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-01-31 | 2023-02-02 | 33,688 | — | $0 | 546,892 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-01-24 | 2023-01-25 | 170,000 | — | $0 | 513,204 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-01-23 | 2023-01-25 | 24,661 | $0.60 | $14.8K | 343,204 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2022-07-19 | 2022-07-20 | 8,281 | $1.10 | $9.1K | 367,865 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-07-18 | 2022-07-20 | 30,000 | — | $0 | 376,146 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2022-01-26 | 2022-01-28 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-01-26 | 2022-01-28 | 85,000 | — | $0 | 346,146 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2021-01-21 | 2021-01-25 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2021-01-21 | 2021-01-25 | 75,000 | — | $0 | 261,146 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2020-01-30 | 2020-02-03 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-01-24 | 2019-01-28 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2019-01-24 | 2019-01-28 | 3,600 | — | $0 | 186,146 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2018-08-06 | 2018-08-07 | 3,800 | $5.79 | $22.0K | 182,546 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-01-11 | 2018-01-16 | 43,920 | — | $0 | 43,920 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2017-01-25 | 2017-01-26 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2015-08-04 | 2015-08-06 | 201,981 | — | $0 | 201,981 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 12,476 | $6.00 | $74.9K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 7,486 | $4.88 | $36.5K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 131,515 | $4.88 | $641.8K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer | 2014-02-21 | 2014-02-25 | 179,182 | $6.80 | $1.22M | 0 | SEC↗ |
| PATH NUPATHE INC. | U Tender | 2014-02-21 | 2014-02-25 | 176,699 | $6.80 | $1.20M | 0 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-06-10 | 2013-06-12 | 30,000 | — | $0 | 360,572 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-01-17 | 2013-01-22 | 125,000 | — | $0 | 330,572 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2013-01-07 | 2013-01-09 | 22,458 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2013-01-07 | 2013-01-09 | 36,150 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-01-07 | 2013-01-09 | 25,907 | — | $0 | 205,572 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-01-07 | 2013-01-09 | 11,229 | — | $0 | 179,665 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-03-08 | 2012-03-27 | 36,150 | — | $0 | 36,150 | SEC↗ |